Market Research Report

Product code

1046312

3D Cell Culture Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Published: December 10, 2021 |

IMARC Services Private Limited | 143 Pages | Delivery time: 2-3 business days

Price

Description
Table of Contents

Add to Compare

The global 3D cell culture market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 11% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

3D cell culture refers to an in-vitro technique used for developing biological cells in a three-dimensional artificial environment. The cell cultures replicate the structure of complex cellular matrices and mimic tissue and organ-specific microarchitectures. They are further observed to gain insights regarding the interaction of cells with the natural environment during radiotherapy, chemotherapy and antibody-based immunotherapy. 3D cell cultures are commonly used in magnetic, bio-printed, scaffold-based and scaffold-free variants. They are widely used for drug screening, development of stem cell therapies and cancer research. In comparison to the traditionally used 2D cell cultures, 3D cell cultures provide an improved simulation of conditions in a living organism and are independent of other cells and tissues.

3D Cell Culture Market Trends:

The increasing prevalence of chronic medical ailments across the globe is one of the key factors driving the growth of the market. The rising preference for personalized medicines among healthcare providers and patients is also providing a thrust to the market growth. 3D cell cultures are extensively used for the development of cancer treatments, stem cell research, drug discovery, toxicology testing and tissue engineering. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the utilization of scaffold-based 3D cell cultures for the discovery and bio-fabrication of antiviral drugs and novel therapeutics. Additionally, the development of advanced microfluidic-based 3D cell cultures with improved cell viability, morphology, proliferation and differentiation is contributing to the growth of the market. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with the increasing requirements for effective alternatives to animal testing, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D cell culture market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Scaffold-Based Platforms
Scaffold-Free Platforms
Microchips
Bioreactors
Others

Breakup by Application:

Cancer Research
Stem Cell Research
Drug Discovery
Regenerative Medicine
Others

Breakup by End User:

Biotechnology and Pharmaceutical Companies
Contract Research Laboratories
Academic Institutes
Others

Breakup by Region:

North America
- United States
- Canada

Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others

Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others

Latin America
- Brazil
- Mexico
- Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3D Biotek LLC, Advanced Biomatrix Inc., Avantor Inc., CN Bio Innovations Limited, Corning Incorporated, Emulate Inc., InSphero AG, Lonza Group AG, Merck KGaA, Promocell GmbH, Synthecon Inc and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

How has the global 3D cell culture market performed so far and how will it perform in the coming years?

What has been the impact of COVID-19 on the global 3D cell culture market?

What are the key regional markets?

What is the breakup of the market based on the product?

What is the breakup of the market based on the application?

What is the breakup of the market based on the end user?

What are the various stages in the value chain of the industry?

What are the key driving factors and challenges in the industry?

What is the structure of the global 3D cell culture market and who are the key players?

What is the degree of competition in the industry?

Product Code: SR1020H371_Report

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global 3D Cell Culture Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Scaffold-Based Platforms
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Scaffold-Free Platforms
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Microchips
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Bioreactors
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Cancer Research
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Stem Cell Research
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Drug Discovery
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Regenerative Medicine
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by End User

8.1 Biotechnology and Pharmaceutical Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Contract Research Laboratories
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Academic Institutes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 3D Biotek LLC
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Advanced Biomatrix Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Avantor Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 CN Bio Innovations Limited
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Corning Incorporated
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Emulate Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 InSphero AG
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Lonza Group AG
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Merck KGaA
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Promocell GmbH
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 Synthecon Inc
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
- 14.3.12 Thermo Fisher Scientific Inc.
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis